For those with Multiple Sclerosis, the progressive manner in which the disease slowly deteriorates motor function, balance, and coordination can make home maintenance an impossibility. Add to this the well-documented issues that MS patients have with finding and keeping jobs and very quickly the cost and effort to maintain a home can become a major heartache.
In response to this, Houston-based exterior home construction and remodeling company Home Exterior Systems recently made an effort help out a member of the MS patient population, and received some heartwarming feedback through a letter from the local family they had done the pro bono work for. Jeff Armbrusters had been suffering from severe multiple sclerosis symptoms and was no longer able to help with the house upkeep. The company responded by remodeling a half wall near their garage, adding siding for the downstairs of the exterior and fixing the rotted upstairs siding, building a new porch cover, and replacing the back door with one that can easily accommodate Jeff.
Jeff’s MS symptoms had progressed to debilitating levels, including intense pain, depression, heat-intolerance, balance problems, and insomnia. In the thank you letter, the team that had worked on the Armbrusters’ house learned that Jeff’s wife was also going through difficult times with her own health, having developed occipital neuralgia, which is a condition that causes severe migraines. Thanks to Home Exterior Systems’ house modifications and repairs, the family can focus on Jeff and his wife’s medical conditions.
The Home Exterior Systems team was able to finish the repairs and remodeling, and helping out the Armbrusters was just one out of many charitable works they have been involved with, having been a contributor to local projects of popular lifestyle cable show Extreme Makeover: Home Edition.
Read more about their charitable work through their website at homeexteriorsystems.com.
In other MS news, pharmaceutical company Genzyme has just announced the US FDA has finally approved Lemtrada (alemtuzumab) for the treatment of relapsing-remitting multiple sclerosis. The drug works by reducing the amount of destructive T and B cells that cause inflammation and damage to the myelin sheath.